STEPAN CO (SCL) Stock Fundamental Analysis

NYSE:SCL • US8585861003

66.78 USD
+0.28 (+0.42%)
At close: Feb 13, 2026
66.78 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, SCL scores 4 out of 10 in our fundamental rating. SCL was compared to 83 industry peers in the Chemicals industry. There are concerns on the financial health of SCL while its profitability can be described as average. SCL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • SCL had positive earnings in the past year.
  • In the past year SCL had a positive cash flow from operations.
  • SCL had positive earnings in each of the past 5 years.
  • SCL had a positive operating cash flow in each of the past 5 years.
SCL Yearly Net Income VS EBIT VS OCF VS FCFSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • SCL's Return On Assets of 1.86% is fine compared to the rest of the industry. SCL outperforms 60.24% of its industry peers.
  • The Return On Equity of SCL (3.63%) is better than 61.45% of its industry peers.
  • With a Return On Invested Capital value of 3.66%, SCL perfoms like the industry average, outperforming 54.22% of the companies in the same industry.
  • SCL had an Average Return On Invested Capital over the past 3 years of 5.63%. This is in line with the industry average of 6.08%.
Industry RankSector Rank
ROA 1.86%
ROE 3.63%
ROIC 3.66%
ROA(3y)3.31%
ROA(5y)4.77%
ROE(3y)6.74%
ROE(5y)9.18%
ROIC(3y)5.63%
ROIC(5y)7.38%
SCL Yearly ROA, ROE, ROICSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • SCL's Profit Margin of 1.96% is fine compared to the rest of the industry. SCL outperforms 60.24% of its industry peers.
  • SCL's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 3.29%, SCL is not doing good in the industry: 65.06% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of SCL has declined.
  • SCL's Gross Margin of 11.94% is on the low side compared to the rest of the industry. SCL is outperformed by 80.72% of its industry peers.
  • SCL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.29%
PM (TTM) 1.96%
GM 11.94%
OM growth 3Y-24.2%
OM growth 5Y-14.3%
PM growth 3Y-26.73%
PM growth 5Y-16.07%
GM growth 3Y-9.55%
GM growth 5Y-7.34%
SCL Yearly Profit, Operating, Gross MarginsSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SCL is destroying value.
  • SCL has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SCL remains at a similar level compared to 5 years ago.
  • SCL has a better debt/assets ratio than last year.
SCL Yearly Shares OutstandingSCL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SCL Yearly Total Debt VS Total AssetsSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.66 indicates that SCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SCL's Altman-Z score of 2.66 is fine compared to the rest of the industry. SCL outperforms 73.49% of its industry peers.
  • The Debt to FCF ratio of SCL is 20.43, which is on the high side as it means it would take SCL, 20.43 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 20.43, SCL perfoms like the industry average, outperforming 48.19% of the companies in the same industry.
  • A Debt/Equity ratio of 0.29 indicates that SCL is not too dependend on debt financing.
  • SCL has a Debt to Equity ratio of 0.29. This is in the better half of the industry: SCL outperforms 78.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 20.43
Altman-Z 2.66
ROIC/WACC0.3
WACC12.14%
SCL Yearly LT Debt VS Equity VS FCFSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • SCL has a Current Ratio of 1.30. This is a normal value and indicates that SCL is financially healthy and should not expect problems in meeting its short term obligations.
  • SCL has a Current ratio of 1.30. This is amonst the worse of the industry: SCL underperforms 83.13% of its industry peers.
  • SCL has a Quick Ratio of 1.30. This is a bad value and indicates that SCL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of SCL (0.84) is worse than 78.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.84
SCL Yearly Current Assets VS Current LiabilitesSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • The earnings per share for SCL have decreased strongly by -18.67% in the last year.
  • The earnings per share for SCL have been decreasing by -15.51% on average. This is quite bad
  • Looking at the last year, SCL shows a small growth in Revenue. The Revenue has grown by 5.35% in the last year.
  • Measured over the past years, SCL shows a small growth in Revenue. The Revenue has been growing by 3.24% on average per year.
EPS 1Y (TTM)-18.67%
EPS 3Y-29.09%
EPS 5Y-15.51%
EPS Q2Q%-53.4%
Revenue 1Y (TTM)5.35%
Revenue growth 3Y-2.41%
Revenue growth 5Y3.24%
Sales Q2Q%7.94%

3.2 Future

  • SCL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.67% yearly.
  • The Revenue is expected to grow by 6.64% on average over the next years.
EPS Next Y3.07%
EPS Next 2Y27.03%
EPS Next 3Y28.67%
EPS Next 5YN/A
Revenue Next Year7.97%
Revenue Next 2Y8.05%
Revenue Next 3Y6.91%
Revenue Next 5Y6.64%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SCL Yearly Revenue VS EstimatesSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
SCL Yearly EPS VS EstimatesSCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 34.07 indicates a quite expensive valuation of SCL.
  • Compared to the rest of the industry, the Price/Earnings ratio of SCL is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.97. SCL is valued slightly more expensive when compared to this.
  • With a Price/Forward Earnings ratio of 18.81, SCL is valued on the expensive side.
  • SCL's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, SCL is valued a bit cheaper.
Industry RankSector Rank
PE 34.07
Fwd PE 18.81
SCL Price Earnings VS Forward Price EarningsSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SCL is valued a bit cheaper than the industry average as 61.45% of the companies are valued more expensively.
  • SCL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 47.09
EV/EBITDA 10.36
SCL Per share dataSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SCL does not grow enough to justify the current Price/Earnings ratio.
  • SCL's earnings are expected to grow with 28.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)11.11
PEG (5Y)N/A
EPS Next 2Y27.03%
EPS Next 3Y28.67%

5

5. Dividend

5.1 Amount

  • SCL has a Yearly Dividend Yield of 2.38%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.16, SCL pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.84, SCL pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.38%

5.2 History

  • On average, the dividend of SCL grows each year by 8.06%, which is quite nice.
  • SCL has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of SCL decreased recently.
Dividend Growth(5Y)8.06%
Div Incr Years1
Div Non Decr Years1
SCL Yearly Dividends per shareSCL Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 76.82% of the earnings are spent on dividend by SCL. This is not a sustainable payout ratio.
  • The dividend of SCL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP76.82%
EPS Next 2Y27.03%
EPS Next 3Y28.67%
SCL Yearly Income VS Free CF VS DividendSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
SCL Dividend Payout.SCL Dividend Payout, showing the Payout Ratio.SCL Dividend Payout.PayoutRetained Earnings

STEPAN CO

NYSE:SCL (2/13/2026, 8:04:00 PM)

After market: 66.78 0 (0%)

66.78

+0.28 (+0.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-29
Earnings (Next)02-23
Inst Owners86.79%
Inst Owner Change0.03%
Ins Owners5.55%
Ins Owner Change9.88%
Market Cap1.51B
Revenue(TTM)2.30B
Net Income(TTM)45.24M
Analysts80
Price Target76.5 (14.56%)
Short Float %1.5%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield 2.38%
Yearly Dividend1.51
Dividend Growth(5Y)8.06%
DP76.82%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.76%
Min EPS beat(2)-42.79%
Max EPS beat(2)-22.72%
EPS beat(4)1
Avg EPS beat(4)-24.99%
Min EPS beat(4)-65.06%
Max EPS beat(4)30.63%
EPS beat(8)3
Avg EPS beat(8)-1.9%
EPS beat(12)4
Avg EPS beat(12)-8.59%
EPS beat(16)7
Avg EPS beat(16)-1.91%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-1.55%
Revenue beat(4)1
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)5.27%
Revenue beat(8)1
Avg Revenue beat(8)-2.38%
Revenue beat(12)2
Avg Revenue beat(12)-3.48%
Revenue beat(16)6
Avg Revenue beat(16)-0.7%
PT rev (1m)-11.76%
PT rev (3m)-11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.14%
EPS NY rev (1m)0%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 34.07
Fwd PE 18.81
P/S 0.66
P/FCF 47.09
P/OCF 9.67
P/B 1.21
P/tB 1.36
EV/EBITDA 10.36
EPS(TTM)1.96
EY2.94%
EPS(NY)3.55
Fwd EY5.32%
FCF(TTM)1.42
FCFY2.12%
OCF(TTM)6.9
OCFY10.34%
SpS101.85
BVpS55.12
TBVpS48.93
PEG (NY)11.11
PEG (5Y)N/A
Graham Number49.3
Profitability
Industry RankSector Rank
ROA 1.86%
ROE 3.63%
ROCE 4.4%
ROIC 3.66%
ROICexc 3.93%
ROICexgc 4.3%
OM 3.29%
PM (TTM) 1.96%
GM 11.94%
FCFM 1.39%
ROA(3y)3.31%
ROA(5y)4.77%
ROE(3y)6.74%
ROE(5y)9.18%
ROIC(3y)5.63%
ROIC(5y)7.38%
ROICexc(3y)6.06%
ROICexc(5y)8.61%
ROICexgc(3y)6.68%
ROICexgc(5y)9.41%
ROCE(3y)6.76%
ROCE(5y)8.87%
ROICexgc growth 3Y-28.84%
ROICexgc growth 5Y-19.33%
ROICexc growth 3Y-28.18%
ROICexc growth 5Y-20.06%
OM growth 3Y-24.2%
OM growth 5Y-14.3%
PM growth 3Y-26.73%
PM growth 5Y-16.07%
GM growth 3Y-9.55%
GM growth 5Y-7.34%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 20.43
Debt/EBITDA 1.81
Cap/Depr 101.87%
Cap/Sales 5.39%
Interest Coverage 2.64
Cash Conversion 79.05%
Profit Quality 70.9%
Current Ratio 1.3
Quick Ratio 0.84
Altman-Z 2.66
F-Score5
WACC12.14%
ROIC/WACC0.3
Cap/Depr(3y)225.06%
Cap/Depr(5y)209.82%
Cap/Sales(3y)9.23%
Cap/Sales(5y)8.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.67%
EPS 3Y-29.09%
EPS 5Y-15.51%
EPS Q2Q%-53.4%
EPS Next Y3.07%
EPS Next 2Y27.03%
EPS Next 3Y28.67%
EPS Next 5YN/A
Revenue 1Y (TTM)5.35%
Revenue growth 3Y-2.41%
Revenue growth 5Y3.24%
Sales Q2Q%7.94%
Revenue Next Year7.97%
Revenue Next 2Y8.05%
Revenue Next 3Y6.91%
Revenue Next 5Y6.64%
EBIT growth 1Y6.39%
EBIT growth 3Y-26.03%
EBIT growth 5Y-11.52%
EBIT Next Year183.79%
EBIT Next 3Y59.09%
EBIT Next 5YN/A
FCF growth 1Y127.16%
FCF growth 3YN/A
FCF growth 5Y-19.02%
OCF growth 1Y-18.57%
OCF growth 3Y30.97%
OCF growth 5Y-5.79%

STEPAN CO / SCL FAQ

What is the fundamental rating for SCL stock?

ChartMill assigns a fundamental rating of 4 / 10 to SCL.


Can you provide the valuation status for STEPAN CO?

ChartMill assigns a valuation rating of 3 / 10 to STEPAN CO (SCL). This can be considered as Overvalued.


Can you provide the profitability details for STEPAN CO?

STEPAN CO (SCL) has a profitability rating of 4 / 10.


What is the financial health of STEPAN CO (SCL) stock?

The financial health rating of STEPAN CO (SCL) is 3 / 10.


How sustainable is the dividend of STEPAN CO (SCL) stock?

The dividend rating of STEPAN CO (SCL) is 5 / 10 and the dividend payout ratio is 76.82%.